The Task Force on the Use of Antiplatelet Agents in Patients with Atherosclerotic Cardiovascular Disease of the European Society of Cardiology
Expert Consensus Document on the Use of Antiplatelet Agents
Similar Content
No improvement in critically ill COVID-19 adult patients with antiplatelet therapy
Antiplatelet therapy administered in critically ill adult patients suffering from COVID-19 does not have an improvement in the number of organ-support ...
Intensified anticoagulation increases the risk of bleeding without any effect on short term mortality in hospitalized patients with COVID-19, shows a meta-analysis
A recent meta-analysis revealed that there was no effect on the short term mortality of the patients hospitalized with COVId-19 with intensified antic ...
Antithrombotic Therapy Not Warranted in COVID-19 Outpatients
Antithrombotic therapy in clinically stable, non-hospitalized COVID-19 patients does not offer protection against adverse cardiovascular or pulmonary ...
Spotlight
Centrix Healthcare Ltd @ 2021. All Rights Reserved